Similar articles

• [Effect of pioglitazone, one of TZDs, on IGT-patients].

  Kobayashi M. Kobayashi M. Nihon Rinsho. 2005 Feb;63 Suppl 2:462-70. Nihon Rinsho. 2005. PMID: 15779423 Japanese. No abstract available.
• [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].

  Yoshimoto K, Ozawa S, Ishida H. Yoshimoto K, et al. Nihon Rinsho. 2005 Feb;63 Suppl 2:95-9. Nihon Rinsho. 2005. PMID: 15779352 Review. Japanese. No abstract available.
• [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].

  Nakamura T. Nakamura T. Nihon Rinsho. 2005 Feb;63 Suppl 2:246-9. Nihon Rinsho. 2005. PMID: 15779380 Review. Japanese. No abstract available.
• [Glucose intolerance: postprandial hyper glucose, risk factor for diabetic macroangiopathy].

  Igarashi Y, Kawamori R. Igarashi Y, et al. Nihon Rinsho. 2006 Nov;64(11):1998-2004. Nihon Rinsho. 2006. PMID: 17087289 Review. Japanese.
• [Significance of insulin measurement in subjects with impaired glucose tolerance or type 2 diabetes].

  Tanaka Y. Tanaka Y. Nihon Rinsho. 2005 Feb;63 Suppl 2:361-5. Nihon Rinsho. 2005. PMID: 15779404 Review. Japanese. No abstract available.